Oxidized low density lipoprotein suppresses expression of inducible cyclooxygenase in human macrophages

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 7, 1999, Pages 1719-1725

  Eligini, Sonia ^a   Colli, Susanna ^a   Basso, Federica ^a   Sironi, Luigi ^a   Tremoli, Elena ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Atherosclerosis; Cyclooxygenase 2; Macrophages; Oxidized lipoproteins; Oxidized phospholipids

Indexed keywords

7 OXOCHOLESTEROL; 7BETA HYDROXYCHOLESTEROL; LOW DENSITY LIPOPROTEIN; LYSOPHOSPHATIDYLCHOLINE; PROSTAGLANDIN SYNTHASE;

ARTICLE; ATHEROGENESIS; ATHEROMA; CELL TRANSFORMATION; ENZYME INDUCTION; ENZYME INHIBITION; FOAM CELL; HUMAN; HUMAN CELL; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033000419     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.7.1719     Document Type: Article

References (56)

1. Gerrity RG. The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. Am J Pathol. 1981;103:181-190.
2. Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature. 1993;362:801-809.
3. Yla-Herttuala S, Palinski W, Rosenfeld ME, Parthasarathy S, Carew TE, Butler S, Witztum JL, Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest. 1989;84:1086-1095.
4. Rosenfeld ME, Khoo JC, Miller E, Parthasarathy S, Palinski W, Witztum JL. Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low-density lipoproteins, and contain oxidation-specific lipid protein adducts. J Clin Invest. 1991;87:90-99.
5. Quinn MT, Parthasarathy S, Steinberg D. Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. Proc Natl Acad Sci U S A. 1988;85:2805-2809.
6. Berliner JA, Territo MC, Sevanian A, Ramin S, Ai Kim J, Bamshad B, Esterson M, Fogelman AM. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest. 1990;85: 1260-1266.
7. Cushing SD, Berliner JA, Valente AJ, Territo MC, Navab M, Parhami F, Gerrity R, Schwartz CJ, Fogelman AM. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci U S A. 1990;87: 5134-5138.
8. Kume N, Cybulsky MI, Gimbrone MA Jr. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest. 1992;90:1138-1144.
9. Libby P. Atheroma: More than mush. Lancet. 1996;348:S4-S6.
10. 2 biosynthesis capacities of heart, arteries and platelets at various stages of experimental atherosclerosis in rabbits. Atherosclerosis. 1978;31:385-394.
11. Larrue J, Rigaud M, Daret D, Demond J, Durand J, Bricaud H. Prostacyclin production by cultured smooth muscle cells from atherosclerotic rabbit aorta. Nature. 1980;285:480-482.
12. Vane JR, Bunting S, Moncada S. Prostacyclin in physiology and pathophysiology. Int Rev Exp Pathol. 1982;23:161-207.
13. Hajjar DP, Weksler BB, Falcone DJ, Hefton JM, Tack-Goldman K, Minick CR. Prostacyclin modulates cholesteryl ester hydrolytic activity by its effect on cyclic adenosine monophosphate in rabbit aortic smooth muscle cells. J Clin Invest. 1982;70:479-488.
14. Moncada S. Prostacyclin and arterial wall biology. Arteriosclerosis. 1982; 2:193-207.
15. Larrue J, Leroux C, Daret D, Bricaud H. Decreased prostaglandin production in cultured smooth muscle cells from atherosclerotic rabbit aorta. Biochim Biophys Acta. 1982;710:257-263.
16. Willis AL, Smith DL, Vigo C. Suppression of principal atherosclerotic mechanisms by prostacyclins and other eicosanoids. Prog Lipid Res. 1986;25:645-666.
17. -) by rabbit blood monocytes. Atherosclerosis. 1986;61: 141-148.
18. Lee SH, Soyoola E, Chanmugam P, Hart S, Sun W, Zhong H, Liou S, Simmons D, Hwang D. Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J Biol Chem. 1992;267:25934-25938.
19. Reddy ST, Herschman HR. Ligand-induced prostaglandin synthesis requires expression of the TIS10/PGS-2 prostaglandin synthase gene in murine fibroblasts and macrophages. J Biol Chem. 1994;269: 15473-15480.
20. Hwang D, Jang BC, Yu G, Boudreau M. Expression of mitogen-inducible cyclooxygenase induced by lipopolysaccharide: mediation through both mitogen-activated protein kinase and NF-κB signaling pathways in macrophages. Biochem Pharmacol. 1997;54:87-96.
21. Mathur SN, Albright E, Field FJ. Decreased prostaglandin production by cholesterol-rich macrophages. J Lipid Res. 1989;30:1385-1395.
22. Arai H, Nagano Y, Narumiya S, Kita T. Decreased arachidonate metabolism in mouse peritoneal macrophages after foam cell transformation with oxidized low-density lipoproteins. J Biochem. 1992;112:482-487.
23. Hamilton TA, Ma G, Chisolm GM. Oxidized low density lipoprotein suppresses the expression of tumor necrosis factor-α mRNA in stimulated murine peritoneal macrophages. J Immunol. 1990;144:2343-2350.
24. Hamilton TA, Major JA, Chisolm GM. The effects of oxidized low density lipoproteins on inducible mouse macrophage gene expression are gene and stimulus dependent. J Clin Invest. 1995;95:2020-2027.
25. Tremoli E, Camera M, Maderna P, Sironi L, Prati L, Colli S, Piovella F, Bernini F, Corsini A, Mussoni L. Increased synthesis of plasminogen activator inhibitor-1 by cultured human endothelial cells exposed to native and modified LDLs: An LDL receptor independent phenomenon. Arterioscler Thromb. 1993;13:338-346.
26. Basu SK, Goldstein JL, Anderson GW, Brown MS, Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. Proc Natl Acad Sci U S A. 1976;73:3178-3182.
27. Palinsky W, Yla-Herttuala S, Rosenfeld ME, Butler SW, Socher SA, Parthasarathy S, Curtiss LK, Witztum JL. Antisera and monoclonal antibodies specific for epitopes generated during oxidative ratification of low density lipoprotein. Arteriosclerosis. 1990;10:325-335.
28. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
29. Watson AD, Leitinger N, Navab M, Faull KF, Horkko S, Witztum JL, Palinski W, Schwenke D, Salomon RG, Sha W, Subbanagounder G, Fogelman AM, Berliner JA. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J Biol Chem. 1997;272:13597-13607.
30. Pierce J, Suelter CH. An evaluation of the Coomassie Brilliant Blue G-250 dye-binding method for quantitative protein determination. Anal Biochem. 1977;81:478-480.
31. Towbin H, Staehein T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979;76:4350-4354.
32. O'Neill GP, Ford-Hutchinson AW. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett. 1993;330: 156-160.
33. Folch J, Lees M, Sloan-Stanley GM. A simple method for isolation of total lipids from animal tissues. J Biol Chem. 1957;226:497-509.
34. Rouser G, Kritchevsky G, Yamamoto A, Simon G, Galli C, Bowman AJ. The ethylaminoethyl and triethylaminoethyl-cellulose column chromatographic procedures for phospholipids, glycolipids and pigments. In: Lowenstein JM, ed. Lipids: Methods in Enzymology. New York: Academic Press Inc; 1969:272-317.
35. Matz CE, Jonas A. Micellar complexes of human apolipoprotein A-1 with phosphatidylcolines and cholesterol prepared from cholate-lipid dispersions. J Biol Chem. 1982;257:4535-4540.
36. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: Modifications of low-density lipoproteins that increase its atherogenicity. N Engl J Med. 1989;320:915-924.
37. Chisolm GM, Ma G, Irwin KC, Martin LL, Gunderson KG, Linberg LF, Morel DW, DiCorleto PE. 7β-hydroperoxycholest-5-en-3β-ol, a component of human atherosclerotic lesions, is the primary cytotoxin of oxidized human low density lipoprotein. Proc Natl Acad Sci U S A. 1994;91:11452-11456.
38. Brown AJ, Leong S, Dean RT, Jessup W. 7-Hydroperoxycholesterol and its products in oxidized low density lipoprotein and human atherosclerotic plaque. J Lipid Res. 1997;38:1730-1745.
39. Sugiyama S, Kugiyama K, Ohgushi M, Fujimoto K, Yasue H. Lysophosphatidylcoline in oxidized low-density lipoprotein increases endothelial susceptibility to polymorphonuclear leukocyte-induced endothelial dysfunction in porcine coronary arteries: Role of protein kinase C. Circulation Res. 1994;74:565-575.
40. Ohlsson BG, Englund MCO, Karlsson ALK, Knutsen E, Erixon C, Skribeck H, Liu Y, Bondjers G, Wiklund O. Oxidized low density lipoprotein inhibits lipopolysaccharide-induced binding of nuclear factor-κB to DNA and the subsequent expression of tumor necrosis factor-α and interleukin-1β in macrophages. J Clin Invest. 1996;98: 78-89.
41. Watson AD, Navab M, Kama SY, Sevanian A, Prescou SM, Stafforini DM, McIntyre TM, La Du BN, Fogelman AM, Berliner JA. Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein. J Clin Invest. 1995;95: 774-782.
42. Han J, Hayar DP, Febbraio M, Nicholson AC. Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36. J Biol Chem. 1997;272:21654-21659.
43. Rigotti A, Acton SL, Krieger M. The class B scavenger receptors SR-B1 and CD36 are receptors for anionic phospholipids. J Biol Chem. 1995; 270:16221-16224.
44. Heery JM, Kozak M, Stafforini DM, Jones DA, Zimmerman GA, McIntyre TM, Prescott SM. Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells. J Clin Invest. 1995;96:2322-2330.
45. Fong LG, Fong TA, Cooper AD. Inhibition of lipopolysaccharide-induced interleukin 1β mRNA expression in mouse macrophages by oxidized low density lipoprotein. J Lipid Res. 1991;32:1899-1910.
46. Thai S-F, Lewis JG, Williams RB, Johnson SP, Adams DO. Effects of oxidized LDL on mononuclear phagocytes: inhibition of induction of four inflammatory cytokine gene RNAs, release of NO, and cytolysis of tumor cells. J Leukoc Biol. 1995;57:427-433.
47. Yang X, Cai B, Sciacca RR, Cannon PJ. Inhibition of inducible nitric oxide synthase in macrophages by oxidized low density lipoproteins. Circulation Res. 1994;74:318-328.
48. Malden LT, Chait A, Raines EW, Ross R. The influence of oxidatively modified low density lipoproteins on expression of platelet-derived growth factor by human monocyte-derived macrophages. J Biol Chem. 1991;266:13901-13907.
49. Moore RN, Pitruzzello FJ, Deana DG, Rouse BT. Endogenous regulation of macrophage proliferation and differentiation by E prostaglandins and interferon αlβ. Lymphokine Res. 1985;4:43-50.
50. Hamilton JA. Coordinate and noncoordinate colony stimulating factor formation by human monocytes. J Leukoc Biol. 1994;55:355-361.
51. Clinton SK, Underwood R, Hayes L, Sherman ML, Kufe DW, Libby P. Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. Am J Pathol. 1992;140: 301-316.
52. Qiao J-H, Tripathi J, Mishra NK, Cai Y, Tripathi S, Wang X-P, Imes S, Fishbein MC, Clinton SK, Libby P, Lusis AJ, Rajavashisth TB. Role of macrophage colony-stimulating factor in atherosclerosis. Am J Pathol. 1997;150:1687-1699.
53. Shackelford RE, Misra UK, Florine-Casteel K, Thai SF, Pizzo SV, Adams DO. Oxidized low density lipoprotein suppresses activation of NF-κB in macrophages via a pertussis toxin-sensitive signaling mechanism. J Biol Chem. 1995;270:3475-3478.
54. Brand K, Eisele T, Kreusel U, Page M, Page S, Haas M, Gerling A, Kaltschmidt C, Neumann FJ, Mackman N, Baeuerle PA, Walli AK, Neumeier D. Dysregulation of monocytic nuclear factor-κB by oxidized low-density lipoprotein. Arterioscler Thromb Vasc Biol. 1997;17: 1901-1909.
55. Muller JM, Ziegler-Heitbrock HWL, Bauerle PA. Nuclear factor kappa B, a mediator of lipopolysaccharide effects. Immunobiology. 1993;187: 233-256.
56. Zhang Y, Rom WN. Regulation of the interleukin-1β (IL-1β) gene by mycobacterial components and lipopolysaccharide is mediated by two nuclear factor-IL6 motifs. Mol Cell Biol. 1993;13:3831-3837.